NEW YORK (GenomeWeb News) – Dow AgroSciences and Chromatin announced this week that they have struck a pair of agreements. The first provides Dow AgroSciences, a subsidiary of Dow Chemical Company, the rights to Chromatin's "mini-chromosome" genetic elements for delivering specific traits into plant cells. The second establishes an exclusive research and license agreement to combine Dow's EXZACT Precision genome-modification technology with mini-chromosomes, creating a technology platform to develop next-generation traits in corn, soybeans, and canola.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.